Serum carnitine and cancer risk: a Mendelian randomization study identifying pancreatic cancer as a modifiable metabolic target.

Discov Oncol · 2025 · PMC12246270 · PMID 40637908

Europe PMC DOI

hedged sentence

0.5600

closest p · 11.2× alpha

0.5600

boldest claim

The sentences

did not reach statistical significanceP = 0.560not close (p > 0.1)

Although the results from the other four methods (Simple mode, Weighted mode, MR Egger, and Weighted median) did not reach statistical significance, the odds ratios were consistently in the same direction as the IVW findings (Simple mode: OR = 1.046, P = 0.560; Weighted mode: OR = 1.035, P = 0.452; MR Egger: OR = 1.007, P = 0.893; Weighted median: OR = 1.046, P = 0.519).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.